Previous research in non-small cell lung cancer has demonstrated that GATA6 downregulation promotes cell migration, proliferation, and cell cycle progression 15, while its deletion in chronic inflammation reduces monocyte recruitment and pro-inflammatory macrophage formation, thus attenuating atherosclerosis 17. This evidence concerns the gene GATA6 and non-small cell lung carcinoma.